Pre-Conference Workshop to the 6th European GMP Conference "How to establish Quality Metrics"

8 June 2015, Heidelberg, Germany

Course No. 9293



Dick Bonner, Qualified Person and ECA Chairman
Karthik Iyer, FDA
Ian Jackson, BSc (Hons) MRSC MHRA, UK
Henny Koch, Qimp Management Systems
Dr Andreas König, Vice President Manufacturing & Quality Aenova-Group
Dr Bernd Renger, Qualified Person and Immediate Past Chairman EQPA


This pre-conference session is designed to discuss the implementation of Quality Metrics in the manufacture of medicinal products and APIs. In the centre will be challenges and possible solutions to identify, measure and report meaningful Quality Metrics. For that purpose the ECA Foundation and its interest group, the European Qualified Person Association, have invited stakeholders from industry and authorities


Quality can be measured on different levels. This can take place on the level of products or processes. It can also be used as a measure of the site`s ability to manufacture products fit for the intended use.

While so far only compliance and non-compliance were measured, Quality Metrics are a new step in the GMP development. Quality Metrics in itself are not new, though. They have already been used in pharmaceutical industry for years – even though mainly internally to measure and optimize the performance. However, currently there is no harmonised approach in place. This means that data can not be compared because of different standards.

The US FDA has set up an initiative to use Quality Metrics for risk based inspections. This development was triggered by the Food and Drug Administration Safety and Innovation Act. However, in Europe agencies also use Quality Metrics. Therefore, a harmonised approach possibly helps regulators worldwide to separate manufacturing sites with very poor standards from those continuously working on quality improvement.

In the end Quality Metrics enable companies with a high quality performance to benefit from a continuous investment in GMP.

Target Group

This Pre-Conference Session addresses Quality and Manufacturing Managers who are involved in the planning and improvement of quality processes.


FDA’s Quality Metrics Program
Overview about the current status
Quality Metrics to support drug quality and surveillance for CDER
Impact for pharmaceutical industry
Karthik Iyer, FDA

The EMA view on Quality Metrics
Quality Metrics - a European Perspective
Globalisation challenges
Key signs of quality culture
How can quality culture be assessed?
Esther Martinez, EMA, UK

Developing, Establishing and Monitoring of Meaningful Quality Metrics in Quality Control
Quality Metrics - Challenges and risks
Benchmarking based on different data sets
Good Quality Control Practices
Lean, Efficient and high Quality - does this fit?
Some meaning Quality Metrics for Lab activities
Dr Bernd Renger, Qualified Person and Immediate Past Chairman EQPA

How to use Quality Metrics to control the Supply Chain and the Supplier
How to oversight the Supply Chain?
Is a complex supply chain always a risk?
How to control and measure the supplier in the supply chain
Supply Chain and Supplier Metrics
Dick Bonner, Qualified Person and ECA Chairman

Inspections based on Compliance Information. The MHRA Risk-Based Inspection Programme
How to anticipate supply chain and compliance risks
How to improve compliance-related communication with industry
Implementation a risk-based escalation process regarding inspection results within MHRA
Ian Jackson, MHRA

Quality Metrics and Management Review
Quality Culture as the basis for quality improvements
How to involve the management in Quality Metrics
Set up of a practical review system
Follow up actions on management reviews
Henny Koch, Qimp Management Systems

Case Study: Quality Metrics at Aenova-Group
Industry Quality Metrics – typical data sets and reports
How to measure Quality Metrics in daily practice
Lessons learned from implementation
Comparison of quality metrics – potential risks and challenges
Dr Andreas König, Senior Vice President corporate Quality & HSE at Aenova-Group

This training/webinar cannot be booked. Send us your inquiry by using the following contact form.

To find alternative dates for this training/webinar or similar events please see the complete list of all events.

For many training courses and webinars, there are also recordings you can order and watch any time. Just take a look at the complete list of all recordings.

* also payable by credit card
American Express Visa Mastercard

Further dates on-site
Further dates on-site
Not available
Further dates online
Further dates online
Not available
Not available

Do you have any questions?

Please contact us:
Tel.: +49 6221 8444-0

Woman with headset

Go back

Testimonials about our courses and conferences

“Fantastic course – I really enjoyed the interactive structure & greatly appreciate social activity.”

Anthony Cummins, Sebela Pharmaceuticals, Ireland
GMP Auditor Practice, September 2023


“Very well organized, information on point without being overwhelming.”

Eleni Kallinikou, Pharmathen
Live Online Trainng - Pharmaceutical Contracts - Febuary 2024


“Good overview of different types of agreements, good to see both the GMP and the legal angle”

Ann Michiels, Johnson&Johnson
Live Online Trainng - Pharmaceutical Contracts, Febuary 2024



“Well prepared presentations and good presenters. I also like the way of asking questions.”

Alexandra Weidler, Hookipa Biotech GmbH, Austria
Live Online Training – QP Education Course Module A, November 2023